Drug Type miRNA |
Synonyms AAV HTTamiRNA, AAVHTTamiRNA |
Target |
Mechanism HTT gene modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Preclinical | US | 08 May 2024 |